A Tale of Two Transparency Attempts at FDA

被引：0

|

作者：

Tai, Laurence ^{[1
]}

机构：

[1] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA

来源：

FOOD AND DRUG LAW JOURNAL | 2013年 / 68卷 / 04期

关键词：

INFORMATION; DISCLOSURE; BUSINESS; SECRETS; HEALTH;

D O I：

暂无

中图分类号：

TS2 [食品工业];

学科分类号：

0832 ;

摘要：

引用

收藏

页码：423 / 447

页数：25

相关论文

共 50 条

[21] FDA transparency rules could hit small companies hardest
Allison, Malorye
NATURE BIOTECHNOLOGY, 2010, 28 (08) : 767 - 768
[22] FDA faces congressional probes and more transparency and organizational changes
Wechsler, Jill
FORMULARY, 2011, 46 (02) : 66 - 67
[23] FDA Task Force unveils next step in Transparency Initiative
Reactions Weekly, 2010, 1303 (1) : 6 - 6
[24] Two Theories of Transparency
Edward W. Averill
Joseph Gottlieb
Erkenntnis, 2021, 86 : 553 - 573
[25] Two Theories of Transparency
Averill, Edward W.
Gottlieb, Joseph
ERKENNTNIS, 2021, 86 (03) : 553 - 573
[26] Perspectives on FDA's attempts to limit functional food development in the US
Zhao, Lu
Wang, Wendan
AGRO FOOD INDUSTRY HI-TECH, 2016, 27 (05): : 6 - 10
[27] A Tale of Two Returns
Stekl, Misha
DELEUZE AND GUATTARI STUDIES, 2023, 17 (01) : 84 - 111
[28] A tale of two kidneys
Gayaparsad, M.
SOUTHERN AFRICAN JOURNAL OF ANAESTHESIA AND ANALGESIA, 2023, 29 (05) : S82 - S87
[29] A tale of two neurotransmitters
Marshak, David W.
VISUAL NEUROSCIENCE, 2016, 33
[30] A Tale of Two Inputs
Ashley, James
Budnik, Vivian
NEURON, 2017, 93 (06) : 1245 - 1247

← 1 2 3 4 5 →